11740 Results

People

  1. Vickers
    Vickers
  2. Offit
    Offit
  3. Robson
    Robson
  4. Horwitz
    Horwitz
  5. Kingham
    Kingham
  6. Panageas
    Panageas
  7. Breitbart
    Breitbart
  8. Halpern
    Halpern
  9. Jarnagin
    Jarnagin
  10. Nelson
    Nelson

Groups

  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)
  7. Psychiatry and Behavioral Sciences, Department of (2780)
  8. Biostatistics Service (2339)
  9. GSK Faculty (2008)
  10. Health Outcomes Research Group (1948)
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (7144)
  2. Meeting Abstract (3306)
  3. Book Section (330)
  4. Review (289)
  5. Editorial (253)
  6. Research Letter (116)
  7. Correspondence (111)
  8. Conference Paper (67)
  9. Guidelines (59)
  10. Miscellaneous (41)
  11. Book Whole (24)
Groups
  1. Population Sciences Research Program (11740)
  2. Survivorship Research (5670)
  3. Department of Medicine (5134)
  4. Epidemiology and Biostatistics (4867)
  5. Solid Tumor Oncology Division (3333)
  6. Surgery (2965)

More Groups

People
  1. Andrew Vickers (880)
  2. Kenneth Offit (788)
  3. Mark Robson (676)
  4. Steven Horwitz (645)
  5. T Peter Kingham (609)
  6. Katherine Panageas (512)

More People

Years
  1. 2025 (235)
  2. 2024 (722)
  3. 2023 (821)
  4. 2022 (828)
  5. 2021 (786)
  6. 2020 (738)

More Years

Publications
  1. Journal of Clinical Oncology (1246)
  2. Blood (374)
  3. Psycho-Oncology (347)
  4. Cancer (240)
  5. Cancer Research (234)
  6. Annals of Surgical Oncology (233)

More Publications

Publishers
  1. American Society of Clinical Oncology (1412)
  2. Elsevier Inc. (1128)
  3. Springer (1112)
  4. Elsevier Science, Inc. (816)
  5. Oxford University Press (753)
  6. Wiley Blackwell (614)

More Publishers

Results (11740)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-surgical visceral adipose tissue may be a novel pre-surgical risk factor for acute kidney injury among clear cell renal cell cancer patients undergoing radical nephrectomy
    Meeting Abstract

    Sanchez, A.; Olson, L.; Knezevic, A.; Akin, O.; Scott, J. S.; Mourtzakis, M.; Hakimi, A. A.; Russo, P.; Jaimies, E.; Bradshaw, P.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Circulating leptin and immune-related transcriptomic patterns in clear cell renal cell carcinoma
    Meeting Abstract

    Posada Calderon, L.; Olsson, L.; Kuo, F.; Dawidek, M.; Barbakoff, D.; Ganz, M.; Jiang, H.; Coleman, J. A.; Russo, P.; Furberg, H.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Reliability of photography-based skin tone annotation using the monk scale and 3D total body photography
    Meeting Abstract

    Weir, V. R.; Gillis, M.; Halpern, A. C.; Rotemberg, V.
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Inherited genetics underlying risk of multiple primary melanoma
    Meeting Abstract

    Gibbs, D. C.; Orlow, I.; Kanetsky, P.; Luo, L.; Cust, A.; Begg, C.; Berwick, M.; Thomas, N.
    Journal of Investigative Dermatology (2024)

    Fulltext@MSK | Save
  • Tamoxifen for breast cancer prevention among survivors of pediatric lymphoma previously treated with chest radiation: Clinical benefits, harms and tradeoffs
    Meeting Abstract

    Yeh, J. M.; Stein, S. K.; Stratton, K.; Taylor, C. S.; Leisenring, W. M.; Alagoz, O.; Armstrong, G. T.; Hudson, M. M.; Jayasekera, J.; Kurian, A. W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • TBCRC 048 (olaparib expanded) expansion cohorts: Phase 2 study of olaparib monotherapy in patients (pts) with metastatic breast cancer (MBC) with germline (g) mutations in PALB2 or somatic (s) mutations in BRCA1 or BRCA2
    Meeting Abstract

    Tung, N. M.; Robson, M. E.; Nanda, R.; Li, T.; Vinayak, S.; Shah, P. D.; Khoury, K.; Kimmick, G. G.; Santa-Maria, C. A.; Brufsky, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Treatment modifications and mortality among female patients with subsequent breast cancer: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Turcotte, L. M.; Hasan, H.; Stene, E.; Monick, S. E.; Rader, R.; Sheade, J.; Wolfe, H. R.; Lu, Z.; Spector, L.; McDonald, A. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Frontline brentuximab vedotin and CHP (A+CHP) in patients (pts) with peripheral T-cell lymphoma with less than 10% CD30 expression: Results from the phase 2 SGN35-032 study
    Meeting Abstract

    Iyer, S. P.; Jagadeesh, D.; Domingo-Domenech, E.; Benedetti, F.; Izquierdo, A. R.; Bouabdallah, K.; Vitolo, U.; Illidge, T. M.; Liu, J.; Shaikh, E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cervical cancer disparities in stage at presentation for disaggregated Asian Americans, Native Hawaiians, and Pacific Islanders
    Meeting Abstract

    Thaploo, A.; Ho, F. D.; Wang, K.; Narayan, A.; Alberto, I.; Ong, E.; Kohli, K.; Kohli, M.; Jain, B.; Dee, E. C. C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient factors associated with chemotherapy modifications: Results from the Optimal Breast Cancer Chemotherapy Dosing (OBCD) study
    Meeting Abstract

    Kantor, E.; Bhimani, J.; Gallagher, G. B.; Blinder, V. S.; Burganowski, R. P.; Griggs, J. J.; Kolevska, T.; Kroenke, C.; Laurent, C.; Liu, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save